Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verification

被引:50
作者
Foloppe, N [1 ]
Fisher, LM [1 ]
Francis, G [1 ]
Howes, R [1 ]
Kierstan, P [1 ]
Potter, A [1 ]
机构
[1] Vernalis R&D Ltd, Cambridge CB1 6GB, England
关键词
drug design; hydrogen bonds; molecular modelling; molecular recognition; oncology; X-ray crystallography;
D O I
10.1016/j.bmc.2005.10.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of the Chk1 kinase by small molecules binding to its active site is a strategy of great therapeutic interest for oncology. We report how computational modelling predicted the binding mode of ligands of special interest to the Chk1 ATP site, for representatives of an indazole series and debromohymenialdisine. These binding modes were subsequently confirmed by X-ray crystallography. The binding mode of a potent indazole derivative involves non-conventional C-H center dot center dot center dot O and N-H center dot center dot center dot pi-aromatic interactions with the protein. These interactions are formed in a buried pocket at the periphery of the ATP-binding site, the importance of which has previously been overlooked for ligand design against Chk1. It is demonstrated that filling this pocket can confer ligands with dramatically enhanced affinity for Chk1. Structural arguments in conjunction with assay data explain why targeting this pocket is also advantageous for selective binding to Chk1. Structural overlays of known inhibitors complexed with Chk1 show that only the indazole series utilizes the pocket of interest. Therefore, the analysis presented here should prove helpful in guiding future structure-based ligand design efforts against Chk1. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1792 / 1804
页数:13
相关论文
共 86 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]  
Barril X, 2004, MINI-REV MED CHEM, V4, P779
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 [J].
Bhat, R ;
Xue, YF ;
Berg, S ;
Hellberg, S ;
Ormö, M ;
Nilsson, Y ;
Radesäter, AC ;
Jerning, E ;
Markgren, PO ;
Borgegård, T ;
Nylöf, M ;
Giménez-Cassina, A ;
Hernández, F ;
Lucas, JJ ;
Díaz-Nido, J ;
Avila, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45937-45945
[5]   High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site [J].
Biondi, RM ;
Komander, D ;
Thomas, CC ;
Lizcano, JM ;
Deak, M ;
Alessi, DR ;
van Aalten, DMF .
EMBO JOURNAL, 2002, 21 (16) :4219-4228
[6]   C-H•••π-interactions in proteins [J].
Brandl, M ;
Weiss, MS ;
Jabs, A ;
Sühnel, J ;
Hilgenfeld, R .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (01) :357-377
[7]  
Busby EC, 2000, CANCER RES, V60, P2108
[8]   The 1.7 Å crystal structure of human cell cycle checkpoint kinase Chk1:: Implications for Chk1 regulation [J].
Chen, P ;
Luo, C ;
Deng, YL ;
Ryan, K ;
Register, J ;
Margosiak, S ;
Tempczyk-Russell, A ;
Nguyen, B ;
Myers, P ;
Lundgren, K ;
Kan, CC ;
O'Connor, PM .
CELL, 2000, 100 (06) :681-692
[9]  
Chen ZH, 2003, MOL CANCER THER, V2, P543
[10]   THE RELATION BETWEEN THE DIVERGENCE OF SEQUENCE AND STRUCTURE IN PROTEINS [J].
CHOTHIA, C ;
LESK, AM .
EMBO JOURNAL, 1986, 5 (04) :823-826